News Shortcuts from other journals

Drug eluting stents not cost effective for low risk patients

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7627.962-a (Published 08 November 2007) Cite this as: BMJ 2007;335:962

In general, drug eluting stents aren't good value for money. They are more expensive than bare metal stents, and European researchers recently estimated that if every patient had one, each cardiac event averted over 18 months would cost an extra €64 732 (£45 000; …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe